StockData
IRadimed Corp logo

IRadimed Corp (IRMD) stock

IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$82.31−1.14 (-1.37%)

Close on Nov 18, 2026Market cap $1.05BP/E 44.0Yield –

IRadimed net income

Net income is the profit left for shareholders after every expense, interest and tax.

IRadimed's net income for the twelve months ending Sep 30, 2026 was $23.98M, up 13.2% year over year. For fiscal 2025 it was $22.48M, up 16.9% from the year before. Over ten years it grew 11.6% a year on average. The highest annual figure on record is $22.48M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$22.48M+16.9%
FY2024Dec 31, 2024$19.23M+11.9%
FY2023Dec 31, 2023$17.19M+34.0%
FY2022Dec 31, 2022$12.83M+37.6%
FY2021Dec 31, 2021$9.33M+581.2%
FY2020Dec 31, 2020$1.37M-85.8%
FY2019Dec 31, 2019$9.63M+52.8%
FY2018Dec 31, 2018$6.30M+1161.3%
FY2017Dec 31, 2017$499.76K-93.1%
FY2016Dec 31, 2016$7.21M-4.2%
FY2015Dec 31, 2015$7.53M+267.2%
FY2014Dec 31, 2014$2.05M+5.9%
FY2013Dec 31, 2013$1.94M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$6.51M+16.7%
Q2 FY2026Jun 30, 2026$5.22M-9.6%
Q1 FY2026Mar 31, 2026$5.82M+24.1%
Q4 FY2025Dec 31, 2025$6.44M+25.2%
Q3 FY2025Sep 30, 2025$5.58M+10.4%
Q2 FY2025Jun 30, 2025$5.77M+17.8%
Q1 FY2025Mar 31, 2025$4.69M+13.3%
Q4 FY2024Dec 31, 2024$5.15M+13.4%
Q3 FY2024Sep 30, 2024$5.05M-0.3%
Q2 FY2024Jun 30, 2024$4.90M+17.3%
Q1 FY2024Mar 31, 2024$4.14M+21.4%
Q4 FY2023Dec 31, 2023$4.54M+23.6%
Q3 FY2023Sep 30, 2023$5.07M+47.9%
Q2 FY2023Jun 30, 2023$4.18M+29.0%
Q1 FY2023Mar 31, 2023$3.41M+37.0%
Q4 FY2022Dec 31, 2022$3.67M-5.6%
Q3 FY2022Sep 30, 2022$3.43M+33.0%
Q2 FY2022Jun 30, 2022$3.24M+120.5%
Q1 FY2022Mar 31, 2022$2.49M+79.3%
Q4 FY2021Dec 31, 2021$3.89M+510.7%
Q3 FY2021Sep 30, 2021$2.58M+139.7%
Q2 FY2021Jun 30, 2021$1.47M–
Q1 FY2021Mar 31, 2021$1.39M-21.6%
Q4 FY2020Dec 31, 2020$637.41K-80.3%
Q3 FY2020Sep 30, 2020$1.07M-56.2%
Q2 FY2020Jun 30, 2020-$2.11M-201.1%
Q1 FY2020Mar 31, 2020$1.77M-4.1%
Q4 FY2019Dec 31, 2019$3.24M+89.9%
Q3 FY2019Sep 30, 2019$2.45M+2.3%
Q2 FY2019Jun 30, 2019$2.09M+54.2%
Q1 FY2019Mar 31, 2019$1.85M+119.4%
Q4 FY2018Dec 31, 2018$1.71M+829.6%
Q3 FY2018Sep 30, 2018$2.40M+1147.6%
Q2 FY2018Jun 30, 2018$1.35M+279.5%
Q1 FY2018Mar 31, 2018$841.20K–
Q4 FY2017Dec 31, 2017$183.64K-83.9%
Q3 FY2017Sep 30, 2017$192.39K–
Q2 FY2017Jun 30, 2017$357.07K–
Q1 FY2017Mar 31, 2017-$233.34K–
Q4 FY2016Dec 31, 2016$1.14M–

More IRadimed figures

See a number that looks wrong?